Holland & Knight Health Dose: February 7, 2023

Contributor

Holland & Knight is a global law firm with nearly 2,000 lawyers in offices throughout the world. Our attorneys provide representation in litigation, business, real estate, healthcare and governmental law. Interdisciplinary practice groups and industry-based teams provide clients with access to attorneys throughout the firm, regardless of location.

Explore Firm Details

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.

United States Food, Drugs, Healthcare, Life Sciences

Holland & Knight Health Doseis an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.

This week's topics include:

President Biden to Release Budget on March 9
Energy and Commerce Committee Addresses the Use of QALYs
Wyden Presses CMS for Details on Drug Pricing Law Implementation
COVID-19 Emergency Declarations End on May 11
CMS Releases Advance Notice of Methodological Changes For 2024 MA, Part D Payment Policies
FTC Signals Increased Enforcement for Unauthorized Health Data Sharing
CMS Releases Guidance on Changes to Medicaid Continuous Enrollment Requirement
340B Contract Pharmacy Limits

Read the full Health Dose»

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.